Supplementary Table and Figure Legends from Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals Article Swipe

PDF

Anne Langkilde , Tine W. Hansen , Steen Ladelund , Allan Linneberg , Ove Andersen , Steen B. Haugaard , Jørgen Jeppesen , Jesper Eugen‐Olsen ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1055-9965.22436013

Supplementary Table and Figure Legends from Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals

Related Topics

Concepts

Cancer Table (database) Urokinase receptor Internal medicine Lung cancer Tumor marker Medicine Oncology Computer science Receptor Data mining

Metadata

Type: supplementary-materials
Language: en
Landing Page: https://doi.org/10.1158/1055-9965.22436013
PDF: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_and_Figure_Legends_from_Increased_Plasma_Soluble_uPAR_Level_Is_a_Risk_Marker_of_Respiratory_Cancer_in_Initially_Cancer-Free_Individuals/22436013/1/files/39885045.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361821042

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361821042

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1055-9965.22436013

Digital Object Identifier
Title: Supplementary Table and Figure Legends from Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals

Work title
Type: supplementary-materials

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Anne Langkilde, Tine W. Hansen, Steen Ladelund, Allan Linneberg, Ove Andersen, Steen B. Haugaard, Jørgen Jeppesen, Jesper Eugen‐Olsen

List of authors in order
Landing page: https://doi.org/10.1158/1055-9965.22436013

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_and_Figure_Legends_from_Increased_Plasma_Soluble_uPAR_Level_Is_a_Risk_Marker_of_Respiratory_Cancer_in_Initially_Cancer-Free_Individuals/22436013/1/files/39885045.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_and_Figure_Legends_from_Increased_Plasma_Soluble_uPAR_Level_Is_a_Risk_Marker_of_Respiratory_Cancer_in_Initially_Cancer-Free_Individuals/22436013/1/files/39885045.pdf

Direct OA link when available
Concepts: Cancer, Table (database), Urokinase receptor, Internal medicine, Lung cancer, Tumor marker, Medicine, Oncology, Computer science, Receptor, Data mining

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361821042
doi	https://doi.org/10.1158/1055-9965.22436013
ids.doi	https://doi.org/10.1158/1055-9965.22436013
ids.openalex	https://openalex.org/W4361821042
fwci
type	supplementary-materials
title	Supplementary Table and Figure Legends from Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11142
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9401000142097473
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1308
topics[0].subfield.display_name	Clinical Biochemistry
topics[0].display_name	Advanced Glycation End Products research
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C121608353
concepts[0].level	2
concepts[0].score	0.6639373302459717
concepts[0].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[0].display_name	Cancer
concepts[1].id	https://openalex.org/C45235069
concepts[1].level	2
concepts[1].score	0.6071767210960388
concepts[1].wikidata	https://www.wikidata.org/wiki/Q278425
concepts[1].display_name	Table (database)
concepts[2].id	https://openalex.org/C56219504
concepts[2].level	3
concepts[2].score	0.5140003561973572
concepts[2].wikidata	https://www.wikidata.org/wiki/Q7900869
concepts[2].display_name	Urokinase receptor
concepts[3].id	https://openalex.org/C126322002
concepts[3].level	1
concepts[3].score	0.47714516520500183
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[3].display_name	Internal medicine
concepts[4].id	https://openalex.org/C2776256026
concepts[4].level	2
concepts[4].score	0.4672550857067108
concepts[4].wikidata	https://www.wikidata.org/wiki/Q47912
concepts[4].display_name	Lung cancer
concepts[5].id	https://openalex.org/C2781447364
concepts[5].level	3
concepts[5].score	0.4509824514389038
concepts[5].wikidata	https://www.wikidata.org/wiki/Q584992
concepts[5].display_name	Tumor marker
concepts[6].id	https://openalex.org/C71924100
concepts[6].level	0
concepts[6].score	0.4123291075229645
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[6].display_name	Medicine
concepts[7].id	https://openalex.org/C143998085
concepts[7].level	1
concepts[7].score	0.3828694820404053
concepts[7].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[7].display_name	Oncology
concepts[8].id	https://openalex.org/C41008148
concepts[8].level	0
concepts[8].score	0.10740572214126587
concepts[8].wikidata	https://www.wikidata.org/wiki/Q21198
concepts[8].display_name	Computer science
concepts[9].id	https://openalex.org/C170493617
concepts[9].level	2
concepts[9].score	0.10415971279144287
concepts[9].wikidata	https://www.wikidata.org/wiki/Q208467
concepts[9].display_name	Receptor
concepts[10].id	https://openalex.org/C124101348
concepts[10].level	1
concepts[10].score	0.06062135100364685
concepts[10].wikidata	https://www.wikidata.org/wiki/Q172491
concepts[10].display_name	Data mining
keywords[0].id	https://openalex.org/keywords/cancer
keywords[0].score	0.6639373302459717
keywords[0].display_name	Cancer
keywords[1].id	https://openalex.org/keywords/table
keywords[1].score	0.6071767210960388
keywords[1].display_name	Table (database)
keywords[2].id	https://openalex.org/keywords/urokinase-receptor
keywords[2].score	0.5140003561973572
keywords[2].display_name	Urokinase receptor
keywords[3].id	https://openalex.org/keywords/internal-medicine
keywords[3].score	0.47714516520500183
keywords[3].display_name	Internal medicine
keywords[4].id	https://openalex.org/keywords/lung-cancer
keywords[4].score	0.4672550857067108
keywords[4].display_name	Lung cancer
keywords[5].id	https://openalex.org/keywords/tumor-marker
keywords[5].score	0.4509824514389038
keywords[5].display_name	Tumor marker
keywords[6].id	https://openalex.org/keywords/medicine
keywords[6].score	0.4123291075229645
keywords[6].display_name	Medicine
keywords[7].id	https://openalex.org/keywords/oncology
keywords[7].score	0.3828694820404053
keywords[7].display_name	Oncology
keywords[8].id	https://openalex.org/keywords/computer-science
keywords[8].score	0.10740572214126587
keywords[8].display_name	Computer science
keywords[9].id	https://openalex.org/keywords/receptor
keywords[9].score	0.10415971279144287
keywords[9].display_name	Receptor
keywords[10].id	https://openalex.org/keywords/data-mining
keywords[10].score	0.06062135100364685
keywords[10].display_name	Data mining
language	en
locations[0].id	doi:10.1158/1055-9965.22436013
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_and_Figure_Legends_from_Increased_Plasma_Soluble_uPAR_Level_Is_a_Risk_Marker_of_Respiratory_Cancer_in_Initially_Cancer-Free_Individuals/22436013/1/files/39885045.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1055-9965.22436013
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5027639219
authorships[0].author.orcid	https://orcid.org/0000-0001-9629-7619
authorships[0].author.display_name	Anne Langkilde
authorships[0].author_position	first
authorships[0].raw_author_name	Anne Langkilde
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5016588114
authorships[1].author.orcid	https://orcid.org/0000-0003-2274-0352
authorships[1].author.display_name	Tine W. Hansen
authorships[1].author_position	middle
authorships[1].raw_author_name	Tine W. Hansen
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5021232216
authorships[2].author.orcid	https://orcid.org/0000-0001-5695-8419
authorships[2].author.display_name	Steen Ladelund
authorships[2].author_position	middle
authorships[2].raw_author_name	Steen Ladelund
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5053605357
authorships[3].author.orcid	https://orcid.org/0000-0002-0994-0184
authorships[3].author.display_name	Allan Linneberg
authorships[3].author_position	middle
authorships[3].raw_author_name	Allan Linneberg
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5026416311
authorships[4].author.orcid	https://orcid.org/0000-0002-2274-548X
authorships[4].author.display_name	Ove Andersen
authorships[4].author_position	middle
authorships[4].raw_author_name	Ove Andersen
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5004437738
authorships[5].author.orcid	https://orcid.org/0000-0002-6827-7036
authorships[5].author.display_name	Steen B. Haugaard
authorships[5].author_position	middle
authorships[5].raw_author_name	Steen B. Haugaard
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5087832746
authorships[6].author.orcid	https://orcid.org/0000-0003-4320-8015
authorships[6].author.display_name	Jørgen Jeppesen
authorships[6].author_position	middle
authorships[6].raw_author_name	Jørgen Jeppesen
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5071706658
authorships[7].author.orcid	https://orcid.org/0000-0002-4630-4275
authorships[7].author.display_name	Jesper Eugen‐Olsen
authorships[7].author_position	last
authorships[7].raw_author_name	Jesper Eugen-Olsen
authorships[7].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_and_Figure_Legends_from_Increased_Plasma_Soluble_uPAR_Level_Is_a_Risk_Marker_of_Respiratory_Cancer_in_Initially_Cancer-Free_Individuals/22436013/1/files/39885045.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Table and Figure Legends from Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11142
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9401000142097473
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1308
primary_topic.subfield.display_name	Clinical Biochemistry
primary_topic.display_name	Advanced Glycation End Products research
related_works	https://openalex.org/W2015711783, https://openalex.org/W2362665920, https://openalex.org/W2465690616, https://openalex.org/W3028981589, https://openalex.org/W2384443056, https://openalex.org/W2356609241, https://openalex.org/W2357263695, https://openalex.org/W2352564820, https://openalex.org/W2360867319, https://openalex.org/W3148573270
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1055-9965.22436013
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_and_Figure_Legends_from_Increased_Plasma_Soluble_uPAR_Level_Is_a_Risk_Marker_of_Respiratory_Cancer_in_Initially_Cancer-Free_Individuals/22436013/1/files/39885045.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1055-9965.22436013
primary_location.id	doi:10.1158/1055-9965.22436013
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_and_Figure_Legends_from_Increased_Plasma_Soluble_uPAR_Level_Is_a_Risk_Marker_of_Respiratory_Cancer_in_Initially_Cancer-Free_Individuals/22436013/1/files/39885045.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1055-9965.22436013
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.a	12
abstract_inverted_index.Is	11
abstract_inverted_index.in	18
abstract_inverted_index.of	15
abstract_inverted_index.and	2
abstract_inverted_index.Risk	13
abstract_inverted_index.from	5
abstract_inverted_index.uPAR	9
abstract_inverted_index.Level	10
abstract_inverted_index.Table	1
abstract_inverted_index.Cancer	17
abstract_inverted_index.Figure	3
abstract_inverted_index.Marker	14
abstract_inverted_index.Plasma	7
abstract_inverted_index.Legends	4
abstract_inverted_index.Soluble	8
abstract_inverted_index.Increased	6
abstract_inverted_index.Initially	19
abstract_inverted_index.Cancer-Free	20
abstract_inverted_index.Individuals	21
abstract_inverted_index.Respiratory	16
abstract_inverted_index.Supplementary	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	8
citation_normalized_percentile.value	0.06751055
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False